LambdaTest and algoQA integration streamlines automation testing, boosts efficiency, and enhances developer productivity, enabling faster time-to-market and cost savings for businesses.
San Francisco, Feb. 29, 2024 (GLOBE NEWSWIRE) -- LambdaTest, a leading cloud-based unified testing platform, announces its integration with algoQA, an end-to-end automation testing platform powered by artificial intelligence. With the seamless integration of these platforms' capabilities, businesses may gain remarkable efficiency and substantially boost developer productivity.
Companies can cut their time-to-market by taking advantage of the combined expertise of LambdaTest and Algoshack to identify and solve issues faster, which will ultimately reduce development costs and improve return on investment.
Teams might precisely plan their testing efforts using this integration, minimizing friction while they progress from test case creation to execution. With a more efficient process, developers may focus on developing high-quality code, as automated testing tackles the task of detecting and reporting potential issues.
"With the integration of algoQA into LambdaTest, users can seamlessly access an extensive online browser farm for automated testing," said Mayank Bhola, Co-Founder and Head of Product at LambdaTest. "This collaboration not only empowers testing teams to achieve greater test coverage and enhance their overall testing efficiency but also significantly boosts developer productivity by streamlining the testing process."
In addition, this integration allows development and testing teams to collaborate and work together to achieve mutual goals. Enhanced testing processes, test insights, and real-time feedback enable stakeholders to make well-informed decisions that lead to software solutions that meet customer expectations.
"After integrating algoQA with LambdaTest, testing teams can streamline their automation test execution processes," stated Jayakishore, Vice President of Product and Technology at Algoshack. "This integration simplifies test execution and helps organizations save time and resources, allowing developers to focus on delivering high-quality products."
For more information about the Algoshack integration with LambdaTest, visit https://www.lambdatest.com/support/docs/algoqa-integration/
About LambdaTest
LambdaTest is an intelligent and omnichannel enterprise execution environment that helps businesses drastically reduce time to market through Just in Time Test Orchestration (JITTO), ensuring quality releases and accelerated digital transformation. Over 10,000+ enterprise customers and 2+ million users across 130+ countries rely on LambdaTest for their testing needs.
● Browser & App Testing Cloud allows users to run both manual and automated tests of web and mobile apps across a wide range of different browsers, real devices, and operating system environments.
● HyperExecute helps customers run and orchestrate test grids in the cloud for any framework and programming language at blazing-fast speeds to cut down on quality test time, helping developers build software faster.
For more information visit https://lambdatest.com
About AlgoShack
AlgoShack is a start-up, born digital, intelligent test automation platform company with a vision to transform software delivery by leveraging Artificial Intelligence and Deep Technology. AlgoShack’s platform algoQA democratizes test automation by inviting participation from everyone in the ecosystem. algoQA produces, within minutes, test cases, datasets & executable test scripts. The easy-to-use platform helps the community auto-generate quality work products that are fit-for-purpose and fit-for-use. Test scripts produced are in the technology or choice and can be executed anywhere.
AlgoShack helps its customers to develop better software faster, significantly reducing their R&D costs, accelerating time to market, enhancing quality, and bringing down business risks.
For more information, please visit, https://algoshack.com/
Contact press@lambdatest.com
-
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cVANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a di2024-06-17
-
Indonesia Stock Exchange Partners with Nasdaq to Upgrade Market InfrastructureTechnology partnership will further enhance overall resilience and integrity of the exchange, while supporting the rapid deployment of new products2024-06-17
-
Adalvo 的 Liraglutide 預充式注射筆成為歐盟首款獲得批准的仿製藥馬爾他聖瓜安, June 17, 2024 (GLOBE NEWSWIRE) -- Adalvo 宣布 Liraglutide 預充式注射筆成功取得 DCP 批准,成為歐盟首款獲得批准的仿製藥。 根據 IQVIA 的報2024-06-17
-
促进生育,助力三胎——“三胎免费生”联合公益行动正式启动为积极响应国家号召实施三胎生育政策,扩大妇幼服务健康供给,在云南省优生优育妇幼保健协会指导下,昆明广播电视台联合昆明安琪儿妇产医院,于6月13日在昆明广播2024-06-17
-
学党史传承红色精神 守党纪筑牢自律防线——平安养老险湖南分公司党支部开展主题党日活动七一前夕,平安养老险湖南分公司党支部全体成员走进“千年学府、百年师范”——湖南第一师范,开展了一次学史明理、学史增信、学史崇德、学史力行的主题党日活动。重2024-06-17